Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 4

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 4
---
 to purchase an aggregate of (i) 428,572 shares of Common Stock previously issued to such investor on April 25, 2024 and (b) 475,824 shares of Common Stock previously issued to such investor on December 13, 2024, in exchange for, among other things, the Company’s agreement to issue the November 2025 Investor Warrant with an exercise price of $29.00 per share. In connection with the Exercise, the Company also issued the November 2025 Placement Agent Warrants with an exercise price of $29.00 per share to StockBlock Securities LLC and its affiliate, Rodman & Renshaw LLC, or their respective designees, who served as the placement agents in connection with such transaction. For more information regarding the November 2025 Warrants, see the section titled “Description of the November 2025 Warrants”.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX”. On December 12, 2025, the last reported sales price per share of our Common Stock was $16.63.

On April 15, 2025, we effected a reverse stock split of our Common Stock at a ratio of 1-for-35 (the “Reverse Stock Split”). Unless otherwise noted, the share and per share information in this prospectus reflects the effect of the Reverse Stock Split.

We are an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this prospectus, together with additional information described under the heading “Where You Can Find More Information”, and any amendments or supplements carefully before you invest in any of our securities.

INVESTING IN OUR COMMON STOCK INVOLVES SUBSTANTIAL RISKS. YOU SHOULD REVIEW CAREFULLY THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING “RISK FACTORS” BEGINNING ON PAGE 21 OF THIS PROSPECTUS.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div